The B2B platform for the best purchasing descision. Identify and compare relevant B2B manufacturers, suppliers and retailers
Close
Filter
Continents
Select continent
Locations
Result types
Company type
Select company type
Industries
Select industry
Company status
Select company status preset
Number of employees
Min.
Max.
Founding year
ACS Biomarker
Amsterdam, Netherlands
A
1-10 Employees
2007
Key takeaway
ACS Biomarker specializes in biomarker discovery and validation, offering a comprehensive range of services that include discovery, validation, and customized data analysis, ensuring optimal data extraction from samples.
Reference
Core business
ACS Biomarker Services
ACS Biomarker is a biotechnology company specialized in biomarker discovery and validation. We offer diverse RNA and protein biomarker services.
engine the biomarker company
Hennigsdorf, Germany
A
1-10 Employees
-
Key takeaway
The company specializes in biomarker discovery, offering innovative high-throughput technologies such as protein and peptide microarrays. With a comprehensive screening service that includes over 10,000 human proteins in a single experiment, they provide scientists with effective solutions for identifying novel biomarkers.
Reference
Core business
Fast Biomarker Discovery with engine Protein Arrays
Discover novel biomarkers with our human protein array. Full screening service with more than 10,000 human proteins in a single experiment.
IMGM Laboratories GmbH
Planegg, Germany
A
11-50 Employees
2001
Key takeaway
IMGM is a dedicated partner for biomarker discovery, utilizing advanced technologies and complex data analysis to provide high-quality results. Their expert team specializes in assay design and validation, offering comprehensive solutions tailored to the needs of the pharmaceutical and biotech sectors.
Reference
Service
IMGM Laboratories GmbH - Biomarker Discovery
Looking for more accurate results?
Find the right companies for free by entering your custom query!
25M+ companies
250M+ products
Free to use
Sciomics - Enabling Precision Medicine
Germany
A
11-50 Employees
2013
Key takeaway
Sciomics is dedicated to advancing biomarker discovery through its innovative scioDiscover microarray platform, enhancing Precision Medicine by developing a diverse pipeline of biomarker signatures for various clinical applications. Their comprehensive services include customized solutions and detailed data analysis, supporting both basic research and pharmaceutical R&D.
Reference
Service
Protein biomarker discovery service | Sciomics
Targos Molecular Pathology GmbH
Kassel, Germany
A
51-100 Employees
2005
Key takeaway
Discovery Life Sciences is dedicated to accelerating biomarker discovery through its extensive biospecimen inventory and multi-omic service laboratories. By providing high-quality biospecimens and reliable biomarker data, they support biopharma, diagnostic, and academic institutions in advancing precision medicine for cancer and other complex conditions.
Reference
Core business
Accelerate Breakthroughs Because Patients Are Waiting® | Discovery Life Sciences
Our mission is to restore hope by speeding the development of innovative diagnostics and effective treatments to improve care.
Affinity Biomarker Labs
London, United Kingdom
A
11-50 Employees
-
Key takeaway
Affinity Biomarker Labs is dedicated to high-quality biomarker analysis, assisting in the discovery, verification, and validation of novel biomarkers, particularly in areas of high unmet need. Their expertise supports the translation of research findings into clinical applications, making them a valuable partner for academic and biopharma organizations in biomarker projects.
Reference
Core business
Home | Affinity Biomarker Labs
OncoMDx Laboratories
Hayward, United States
B
11-50 Employees
2009
Key takeaway
Core Diagnostics offers comprehensive biomarker services, supporting clients from early research to Phase III clinical trial analyses. Their expertise in molecular testing and advanced laboratory facilities positions them as a key player in biomarker discovery for clinical research and diagnosis.
Reference
Service
Biomarker Services in Drug Development - Core DiagnosticsCore Diagnostics
Proteome Sciences
London, United Kingdom
A
11-50 Employees
1993
Key takeaway
The company's expertise in proteomics supports biomarker discovery by measuring proteins, which is essential for developing more effective and efficient healthcare solutions. Their innovative proteomic services aim to enhance targeted therapeutics.
Reference
Service
Biomarker Discovery
Talon Biomarkers
Mendham, United States
B
1-10 Employees
2021
Key takeaway
Talon Biomarkers provides advanced solutions for effective biomarker discovery, emphasizing fast and thorough data analysis to accurately identify the cell types responsible for patient variations.
Reference
Core business
Home | Talon Biomarkers
Nordic Preclinical Sciences AB
Stockholm, Sweden
A
1-10 Employees
-
Key takeaway
The company specializes in biomarker discovery through expert services in proteomics, transcriptomics, and bioinformatics analyses, particularly in therapeutic areas like oncology and immunology. They aim to support preclinical research in drug development by providing access to cutting-edge techniques.
Reference
Service
Nordic Preclinical Sciences - Biomarker Discovery
Technologies which have been searched by others and may be interesting for you:
Biomarker discovery involves identifying biological markers that can be used to detect or predict disease progression, treatment responses, or patient outcomes. This process is crucial in personalized medicine, as biomarkers can help tailor therapies to individual patients based on their unique biological profiles. Advanced technologies like genomics, proteomics, and metabolomics play a significant role in biomarker discovery, allowing researchers to analyze complex biological data. By understanding the molecular changes associated with diseases, scientists can develop more effective diagnostic tools and therapeutic strategies, improving patient care and health outcomes.
Biomarker discovery plays a crucial role in personalized medicine by identifying specific biological markers that can indicate how a patient will respond to certain treatments. These biomarkers can be proteins, genes, or other molecules that help in understanding the disease at a molecular level. By utilizing biomarkers, healthcare providers can tailor treatment plans to the individual characteristics of each patient, ensuring more effective and targeted therapies. This approach not only enhances treatment efficacy but also minimizes the risk of adverse effects, leading to improved patient outcomes.
The field of biomarker discovery faces several significant challenges. One major hurdle is the complex nature of biological systems, which can lead to variability in results. This variability makes it difficult to identify consistent and reliable biomarkers across different populations. Additionally, the integration of large datasets from various sources poses a challenge in ensuring data quality and relevance. Another issue is the regulatory environment, which can slow down the validation and approval processes for new biomarkers. Researchers often struggle with translating findings from research settings into clinical applications, as the context in which biomarkers are discovered may not always align with real-world scenarios. These challenges highlight the need for innovative approaches and collaboration among stakeholders to advance biomarker discovery effectively.
Technological advancements significantly enhance biomarker discovery by improving the accuracy and efficiency of identifying potential biomarkers. Innovations in genomics, proteomics, and metabolomics facilitate high-throughput screening, allowing researchers to analyze vast amounts of data quickly. Advanced imaging techniques and bioinformatics tools enable the detection of subtle changes in biological samples, which can lead to the identification of novel biomarkers associated with diseases. Moreover, machine learning and artificial intelligence play a crucial role in processing complex datasets, revealing patterns and correlations that might be overlooked by traditional methods. These technologies not only accelerate the discovery process but also reduce costs, ultimately advancing personalized medicine and enhancing patient care through more targeted therapies.
Key applications of biomarker discovery in healthcare encompass several critical areas.
1. Disease Diagnosis
Biomarkers play a significant role in the early detection and diagnosis of diseases, including cancer, cardiovascular conditions, and neurodegenerative disorders. They help in identifying specific biological indicators that can signal the presence of a particular disease, allowing for timely intervention.
2. Treatment Monitoring
Another essential application is in monitoring treatment responses. Biomarkers can provide insights into how well a patient is responding to therapy, enabling healthcare providers to adjust treatment plans as necessary and improve patient outcomes.
3. Personalized Medicine
In the realm of personalized medicine, biomarker discovery aids in tailoring treatments to individual patients based on their unique biological profiles. This approach enhances the effectiveness of therapies and minimizes adverse effects by ensuring that patients receive the most suitable interventions.
4. Drug Development
Biomarkers are also vital in drug development processes. They assist in identifying potential therapeutic targets, predicting drug efficacy, and assessing safety, ultimately streamlining the path from research to market for new treatments.
Some interesting numbers and facts about your company results for Biomarker Discovery
| Country with most fitting companies | United States |
| Amount of fitting manufacturers | 7969 |
| Amount of suitable service providers | 6357 |
| Average amount of employees | 11-50 |
| Oldest suiting company | 1993 |
| Youngest suiting company | 2021 |
20%
40%
60%
80%
Some interesting questions that has been asked about the results you have just received for Biomarker Discovery
What are related technologies to Biomarker Discovery?
Based on our calculations related technologies to Biomarker Discovery are Biomedical (Red), Bioinformatics (Gold), Environmental Biotechnology (Grey), Agricultural Biotechnology (Green), Food Related Biotechnology (Yellow)
Who are Start-Ups in the field of Biomarker Discovery?
Start-Ups who are working in Biomarker Discovery are Talon Biomarkers
Which industries are mostly working on Biomarker Discovery?
The most represented industries which are working in Biomarker Discovery are Biotechnology, Other, Medical, Healthcare, IT, Software and Services
How does ensun find these Biomarker Discovery Companies?
ensun uses an advanced search and ranking system capable of sifting through millions of companies and hundreds of millions of products and services to identify suitable matches. This is achieved by leveraging cutting-edge technologies, including Artificial Intelligence.
